Enzymit’s mission is to create the knowledge and tools to design and build novel biomolecular components, pathways, and networks to rewire and reprogram organisms to supply humanity’s needs. Its technology aims to improve existing enzyme functionality, at a fraction of the cost and time of alternative approaches, and to invent new enzymes to address unmet market needs.

Enzymit is an alum of MassChallenge Israel’s 2020 industry-agnostic accelerator. After completing the accelerator, Enzymit closed its seed round in April 2022.